Surufatinib Hepatic Impairment Study

Clinical trial NCT04755075 · COMPLETED

Trial details

NCT number: NCT04755075
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2021-02-12
Primary completion: 2021-10-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.